| Net income | 715M |
| Depreciation and amortization | 739M |
| Provision for uncollectible accounts | 39M |
| Deferred income taxes and other noncash items | 173M |
| Impairment and other charges | |
| Stock-based compensation | 57M |
| Receivables | 20M |
| Other assets | -4M |
| Pension assets and liabilities, net | |
| Accounts payable and other liabilities | -753M |
| Other, net | -15M |
| Cash provided by operating activities | |
| Capital expenditures | -1.22B |
| Business acquisition, net of cash acquired | |
| Proceeds from asset dispositions and other | 9M |
| Cash used in investing activities | |
| Principal payments on debt | -12M |
| Proceeds from debt issuance | |
| Proceeds from stock issuances | 40M |
| Excess tax benefit on the exercise of stock options | 2M |
| Dividends paid | -106M |
| Other, net | -15M |
| Cash (used in) provided by financing activities | |
| Effect of exchange rate changes on cash | 3M |
| Net increase (decrease) in cash and cash equivalents | -545M |
| Cash and cash equivalents at beginning of period | 3.53B |
| Cash and cash equivalents at end of period | 2.99B |